Raina Olexa has over 20 years of medical research and pharmaceutical experience, working across all stages of the product lifecycle. She conducted pre-clinical neurobiology research to assess recovery of function in animal models of spinal cord injury before moving into the field of vaccine and biologics manufacturing.

After gaining significant GMP experience, Ms. Olexa transitioned into clinical research ensuring that international Phase I-IV clinical trials are conducted ethically and in accordance with global regulations. She currently supports quality and regulatory science efforts for real world evidence projects, focusing on RWE for regulatory decision making.